Related Experiment Videos
Pernicious syndromes in Plasmodium infections
The Medical Journal of Australia
|December 11, 1982
Summary
Plasmodium vivax and Plasmodium falciparum malaria can cause severe pernicious syndromes, with mixed infections presenting the highest complication rates. Early recognition and treatment are crucial for recovery from this preventable disease.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Parasitology
Background:
- Malaria remains a significant global health challenge, particularly in tropical regions.
- Plasmodium vivax and Plasmodium falciparum are the most prevalent malaria species affecting humans.
- Pernicious syndromes represent severe, life-threatening complications of malaria.
Purpose of the Study:
- To determine the prevalence of pernicious syndromes in male patients with malaria in northeastern India.
- To analyze the association between malaria species (P. vivax, P. falciparum, mixed) and the occurrence of pernicious syndromes.
- To identify common complications associated with malaria infections.
Main Methods:
- Retrospective analysis of medical records of 560 male patients admitted between June 1978 and June 1980.
- Categorization of patients based on malaria parasite species: P. vivax, P. falciparum, or mixed infection.
- Documentation and classification of observed pernicious syndromes and organ involvement.
Main Results:
- Of 560 patients, 31.8% had P. vivax, 55.1% had P. falciparum, and 13.1% had mixed infections.
- Pernicious syndromes were observed in 68 patients (12.1%), with cerebral and hematopoietic complications being most frequent (29.4% and 47.1%).
- Complication rates were lowest in P. vivax malaria (2.3%), higher in P. falciparum malaria (14.2%), and highest in mixed infections (27.4%).
Conclusions:
- Plasmodium falciparum and mixed malaria infections are associated with a higher risk of developing pernicious syndromes compared to P. vivax malaria.
- Cerebral and hematopoietic complications are significant concerns in severe malaria cases.
- Timely diagnosis and appropriate therapy are essential for improving patient outcomes in malaria.